[ Price : $8.95]
FDA cites Aurobindo Pharma USA for multiple failures to comply with federal drug supply chain security requirements, including del...[ Price : $8.95]
AVID Medical recalls (Class 1 device correction) certain organ recovery and medical convenience kits.[ Price : $8.95]
FDA grants Alessa Therapeutics a fast track designation for Enolen, an experimental localized prostate cancer therapy.[ Price : $8.95]
A new FDA guidance details how drug developers can appropriately use Bayesian statistical methods in clinical trials intended to s...[ Price : $8.95]
FDA tells Aquestive Therapeutics that deficiencies have been identified in the companys NDA for Anaphylm that currently preclude l...[ Price : $8.95]
FDA accepts for review a Camurus NDA resubmission for Oclaiz (octreotide), a once-monthly treatment for acromegaly.[ Price : $8.95]
A December FDA violation letter targeting a schizophrenia drug advertisement from Bristol Myers Squibbs Karuna Therapeutics unit u...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion sends BeOne Medicines USA an untitled letter over its promotional materials for cancer...